Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation of Executive Function in the ADHD Brain

NCT04175028 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04175028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation of Executive Function in the ADHD Brain
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
June 1, 2018
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder